Kliničke studije za Lupus u državi Iowa
6 studija za Lupus traži sudionike na lokacijama u državi Iowa.
Gradovi u državi Iowa
Službeni tekst studije (engleski)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50319, Iowa City
U tijeku regrutacijaFaza 3
Od 16 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06617325A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, Iowa City
U tijeku regrutacijaFaza 1
Od 18 do 70 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT06916806A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- University of Iowa, Iowa City
U tijeku regrutacijaFaza 1
Od 18 do 74 godina · Oba spola · Ažurirano 10. ruj 2026. · NCT07085104A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- University of Iowa, Iowa City
U tijeku regrutacijaFaza 1
Od 18 do 70 godina · Oba spola · Ažurirano 28. kol 2026. · NCT06925542Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
- Univeristy of Iowa, Iowa City
U tijeku regrutacija
Od 18 do 100 godina · Oba spola · Ažurirano 10. kol 2026. · NCT07180537A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- University of Iowa, Iowa City
U tijeku regrutacijaFaza 1
Od 18 do 70 godina · Oba spola · Ažurirano 5. lip 2026. · NCT06613360Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.